The Intermediate Conductance Calcium-activated Potassium Channel KCa3.1 Regulates Vascular Smooth Muscle Cell Proliferation via Controlling Calcium-dependent Signaling
Open Access
- 1 May 2013
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 288 (22), 15843-15853
- https://doi.org/10.1074/jbc.m112.427187
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Therapeutic potential of KCa3.1 blockers: recent advances and promising trendsExpert Review of Clinical Pharmacology, 2010
- Regulation of cell proliferation by intermediate-conductance Ca2+-activated potassium and volume-sensitive chloride channels in mouse mesenchymal stem cellsAmerican Journal of Physiology-Cell Physiology, 2008
- Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a New Activator of KCa2 and KCa3.1 Potassium Channels, Potentiates the Endothelium-Derived Hyperpolarizing Factor Response and Lowers Blood PressureMolecular Pharmacology, 2008
- The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humansJCI Insight, 2008
- Local Delivery of the K Ca 3.1 Blocker, TRAM-34, Prevents Acute Angioplasty-Induced Coronary Smooth Muscle Phenotypic Modulation and Limits StenosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Effects of memantine on mitochondrial functionBiochemical Pharmacology, 2008
- Mitogenic modulation of Ca2+‐activated K+ channels in proliferating A7r5 vascular smooth muscle cellsBritish Journal of Pharmacology, 2006
- Ca 2+ , Calmodulin, and Cyclins in Vascular Smooth Muscle Cell CycleCirculation Research, 2006
- Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for RestenosisCirculation, 2003
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001